|
RAB3IP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.117600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.744300E-02 |
| Normal-vs-Stage2 |
4.900200E-01 |
| Normal-vs-Stage3 |
1.804850E-04 |
| Normal-vs-Stage4 |
2.864100E-03 |
| Stage1-vs-Stage2 |
2.645200E-01 |
| Stage1-vs-Stage3 |
3.812300E-02 |
| Stage1-vs-Stage4 |
2.047400E-01 |
| Stage2-vs-Stage3 |
3.353600E-02 |
| Stage2-vs-Stage4 |
7.867800E-02 |
| Stage3-vs-Stage4 |
7.748600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.763170E-03 |
| Normal-vs-AfricanAmerican |
1.861440E-01 |
| Normal-vs-Asian |
9.658100E-03 |
| Caucasian-vs-AfricanAmerican |
3.728600E-01 |
| Caucasian-vs-Asian |
9.787800E-01 |
| AfricanAmerican-vs-Asian |
3.606400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.537500E-03 |
| Normal-vs-Female |
1.603610E-02 |
| Male-vs-Female |
2.842400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.690300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.579000E-03 |
| Normal-vs-Age(61-80Yrs) |
9.475800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.756200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.698000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.647600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.229600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.137600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.581400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.552400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.484600E-03 |
| Classical-VS-Follicular |
9.325800E-02 |
| Classical-VS-Other |
4.215600E-01 |
| Classical-VS-Normal |
3.676600E-03 |
| Tall-VS-Follicular |
8.229800E-04 |
| Tall-VS-Other |
8.213600E-01 |
| Tall-VS-Normal |
1.61022999999316E-05 |
| Follicular-VS-Other |
3.042600E-01 |
| Follicular-VS-Normal |
5.095200E-01 |
| Other-VS-Normal |
6.329600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.518700E-03 |
| Normal-vs-N1 |
4.596500E-04 |
| N0-vs-N1 |
1.638570E-01 |
|
|
